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Autonomic neuropathies are normally subclinical in
diabetic children and adolescents, but in poorly con-
trolled patients may be extremely symptomatic [1].
Gastrointestinal (GI) autonomic dysfunction may include
esophageal dysmotility, gastroparesis, dysfunction of in-
testinal neurons, and decreased/absence of gastrocolic
reflex [1, 2]. We report a case of a diabetic boy who had
a severe GI dysautonomia related with longstanding
poorly controlled diabetes, which reverted following the
restoration of glycemic control.
A 15-year-old boy recurred to our hospital emergency
unit due to persistent nausea and vomiting, anorexia,
weight loss and constipation, with one-week onset and
progressive worsening. His medical past was remarkable
for type 1 diabetes under intensive insulin therapy, with
irregular therapeutical compliance. He confessed rare use
of prandial insulin which motivated several past admis-
sions due to diabetic ketoacidosis. At admission, physical
examination was noteworthy for abdominal distention
with pain, lack of GI sounds, and increased tympanism.
Laboratorial data were remarkable for hyperglycemia
(290 mg/dL) and ketonemia (0.9 mmol/L) with no aci-
dosis (pH 7.46); glycated hemoglobin was 17.5 %. Ab-
dominal X-ray and computed tomography (CT) scan
revealed exuberant gastric and bowel distention with
stasis (Fig. 1). An endoscopic study showed alimentary
impaction at stomach. The patient was managed with
continuous intravenous insulin, parenteral nutrition, me-
toclopramide, and erythromycin. Glycemia was fastly
controlled and patient´s complaints significantly improved.
Ten days after, he started oral feeding with tolerance and
resolution of dyspepsia and constipation was perceived.
Abdominal X-ray and barium esophagram confirmed
resolution of GI tract distention and stasis. The patient
was discharged two weeks after the admission absolutely
asymptomatic.
Gastric emptying and GI motility involve complex
coordination of enteric nervous, hormonal, and smooth
muscle systems [2]. The pathogenesis of GI dysautono-
mia is multifactorial involving cellular changes, increased
oxidative stress, autoimmune and inflammatory factors,
impaired hormonal regulation, and genetic predisposition
[1]. Acute hyperglycemia has been demonstrated to in-
duce relaxation of the stomach, increased pyloric tone,
and suppression of peristalsis [3]. Moreover, acute gly-
cemic fluctuations may adversely affect GI function [3].
GI dysmotility may lead to unpleasant GI manifestations,
deterioration of nutritional status, or unpredictable oscil-
lations of glycemia due to irregular absorption of food/
medication [1, 2]. However, rarely can be life-threatening
and may lead to long periods of debilitating GI symp-
toms requiring prolonged hospital admissions [2, 3].
Gastroparesis is the commonest GI dysautonomia, but
constipation, diarrhea, and more rarely megacolon or
colonic pseudo-obstruction, stercoral ulcer or viscera
perforation may occur [3]. The chronic nonadherence to
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insulin therapy, with consequent poor glycemic control,
predisposed our patient to this severe GI dysautonomia.
The management of severe GI dysautonomia may in-
volve support therapy (fluids, parenteral nutrition), symp-
tomatic therapy (analgesics, antiemetics, prokinetics,
erythromycin, proton pump inhibitors, laxatives), but the
mainstay approach consists in the restoration of eug-
lycemia. It has been reported that continuous subcutaneous
insulin infusion in diabetic gastroparesis improves the
glycemic control, reduces glycemic variability, and the
frequency of hypoglycemia, as well as decreases the
number of hospitalization days [3]. In our patient, the use
of continuous intravenous insulin infusion allows us to
obtain glycemic control, and together with prokinetics
agents, reverted fastly the severe GI condition.
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Fig. 1 Abdominal X-ray and
computed tomography scan
images of our patient showing
exuberant gastric and bowel
distention with stasis
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